Diabetes

Patient-centered diabetes care is most effective when targeted to patients with HbA1c >8.5 percent, according to a study.

After the FDA warning and removal of rosiglitazone from the VA National Formulary, glucose control may have declined among those discontinuing rosiglitazone without receiving replacement medication.

Access to affordable, quality healthcare for poor Americans varies dramatically among the states, according to a new study that found a wide disparity in measures of health between states with the best healthcare systems and those with the worst.

As healthcare delivery evolves to be more efficient and cost-effective, health technology continues to show the biggest promise.

Mark Fendrick, MD, co-editor-in-chief of The American Journal of Managed Care, concludes the PCDC event with his closing remarks.

Deneen Vojta, MD, says cheaper, better, more accessible healthcare is something we all want. Big data, value-based insurance design, and value-based contacting are all factors that might help the industry get there.

Jan Berger, MD, MJ, The American Journal of Pharmacy Benefits editor-in-chief, follows Rebecca Killon's remarks with her own insight on the importance of diabetes medication adherence.

Rebecca W. Killon, MA, says addressing adherence of diabetes medication from the patient perspective can be very different from that of a physician.

Josh Benner, PharmD, ScD, says nonadherence in diabetes medication is a large contributor to high costs in healthcare and should be a priority for care givers.

Darius Lakdawalla, PhD, addresses the value of diabetes patients' adherence in this clip.

Amitabh Chandra, PhD, says health reform affects patient-centered diabetes care through two different interventions.

Tomas Philipson, PhD, says historical reform efforts in the United States have raised doubts as to whether or not the implementation of the Affordable Care Act will slow health spending growth. Dr Philipson also suggests that concepts of value-based insurance design must be considered differently when managing a chronic condition like diabetes.

A new report finds that the US healthcare system could save more than $200 billion a year if prescription medications were more prudently administered.

Fluoroquinolone antibiotics are associated with an increased risk of blood glucose swings in diabetic patients, researchers reported.

An inhaled insulin device made by MannKind Corp proved more effective than injected and oral treatments in trials, potentially improving the quality of life for millions of diabetics.

Adherence to medication can improve healthcare outcomes but is associated with higher total healthcare expenses, especially during the years immediately following the onset of diabetes.

Economists specialize in pointing out unpleasant trade-offs - a skill that is on full display in the health care debate.

Wade M. Aubry, MD, associate clinical professor, University of California, San Francisco, continues discussions saying that comparative effectiveness research (CER) and the evolution of evidence-based medicine can facilitate innovations under the Affordable Care Act (ACA), especially with the inclusion of value-based insurance design (VBID).

The effort to drive quality-based performance in physicians is now evident in the provision of preventive medicine.

Albert Tzeel says providers must consider how aspects of the changing healthcare landscape may affect their performance.

Annual ACO survey shows care coordination remains a work in progress for many providers.